Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2025 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 Accendra Health, Inc. (Exact name of registrant as specified in its charter) Virginia 54-1701843 (State or other jurisdiction of (I.R ...

Exhibit 99.1 Accendra Health Reports Fourth Quarter 2025 Financial Results Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter RICHMOND, VA – February 19, 2026 – Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment ...

Core Viewpoint Orosur Mining Inc. has reported its unaudited financial results for the quarter ending November 30, 2025, highlighting significant operational developments in Colombia and Argentina, alongside a notable increase in cash reserves. Operational Highlights - Infill drilling at the Pepas gold prospect in Colombia is ongoing, aimed at achieving a NI43-101 compliant Mineral Resource Estimate (MRE), expected by the end of January 2026. Drilling results have confirmed the high-grade mineralization of the Pepas deposit [3]. - A large-scale soil geochemical survey at El Cedro, located 10 km south of Pepas, has identified a substantial gold-bearing system with assays exceeding 1g/t Au [3]. - A second porphyry system has been identified south of El Cedro through new geochemical data analysis combined with historical mapping and airborne geophysical data [4]. - In Argentina, the company has acquired a 51% interest in Deseado Dorado S.A.S, which owns the El Pantano Project. A Phase 2 joint venture will lead to 100% ownership upon an additional investment of US$2 million, with a 3,000-meter drill program already underway [4]. - The initial drilling at El Pantano has confirmed the presence of a low sulphidation epithermal mineral system, with further assay results pending [4]. - The company has decided to withdraw from its lithium project in Nigeria to prioritize capital and human resources, with the investment in Nigeria fully impaired as of May 31, 2025 [4]. Financial Highlights - As of November 30, 2025, the company reported a cash balance of US$16,280,000, a significant increase from US$4,877,000 on May 31, 2025 [7]. - The company completed a brokered private placement on October 2, 2025, raising CAD$20 million through the issuance of common shares, which was oversubscribed [7]. - The total assets increased to US$23,593,000 from US$9,489,000, while total liabilities decreased to US$4,884,000 from US$12,858,000 [6]. - The net loss for the period was reported at US$4,543,000, compared to a net income of US$1,870,000 in the same period last year [8].

Core Viewpoint - The completion of the sale of the Products & Healthcare Services (P&HS) segment marks a strategic transformation for Owens & Minor, which is now rebranded as Accendra Health, focusing on home-based care solutions [2][4]. Group 1: Company Transformation - The sale of the P&HS segment to Platinum Equity for $375 million in cash allows the company to concentrate on becoming a leading home-based care platform [4]. - The company aims to support patients with chronic conditions by providing necessary resources for home-based care, enhancing its focus and resilience [2][3]. Group 2: Future Strategy - Accendra Health will focus on its Apria and Byram brands, aligning capital deployment and corporate strategy to foster durable growth and long-term value creation [3]. - The company retains a 5% equity stake in the P&HS segment and preserves tax attributes exceeding $150 million, which may benefit future financial performance [4].

Core Viewpoint - Orosur Mining Inc. has announced the admission of 666,664 common shares following the exercise of options by consultants, bringing the total number of common shares issued to 392,689,176 [1] Group 1 - The company operates as a minerals explorer and developer with projects located in Colombia and Argentina [1] - The admission of shares occurred on December 16, 2025, as part of a previously announced exercise of options [1] - No warrants were exercised during December, resulting in no additional common shares being issued from the company's block listing [1]

Core Insights - Investors in Owens & Minor (OMI) have experienced a significant decline in share value, losing approximately 75% in 2025 due to the company's decision to back off an ill-conceived acquisition [1] Company Performance - The company's stock performance has been severely impacted, reflecting a lack of confidence in its strategic decisions [1] Market Sentiment - The drastic drop in share value indicates a negative market sentiment towards Owens & Minor, suggesting that investors are wary of the company's future prospects [1]

Core Points - Orosur Mining Inc. has issued 666,664 common shares, representing 0.17% of the current issued share capital, following the exercise of options by consultants [1] - The exercise price for the options was C$ 0.06 per share [1] - Omar Gonzalez, the external Chief Financial Officer, exercised 166,666 options and now holds 166,666 common shares, which is 0.04% of the company's issued share capital [1]

Core Insights - Orosur Mining Inc. has reported significant progress in its exploration activities at El Pantano in Argentina and Anzá in Colombia, highlighting the discovery of a low sulphidation epithermal mineral system at El Pantano [1] Group 1: Exploration Activities - The drilling program at El Pantano has yielded assays for five holes, with notable results including PEP067, which returned 83.7 meters at 4.29 grams per tonne (g/t) of gold from surface [1] - Resource modeling and the NI43-101 report process are currently underway for the findings at El Pantano [1] Group 2: Mineral System Confirmation - The initial holes from the El Pantano drilling program have confirmed the presence of a low sulphidation epithermal mineral system, with further assays pending [1]

Group 1 - The sale of the P&HS business is now definitive, although it still requires closure and is subject to FTC review, indicating increased certainty around the transaction [1] - The company has transitioned to a pure-play Patient Direct business, which will allow for a more focused operational strategy and capital allocation [2] - With the constraints from the P&HS business removed, the company can now invest more aggressively in technology, sales, and product categories to accelerate growth [2]

Core Points - Orosur Mining Inc. has announced the posting of the Notice of Annual and Special Meeting to shareholders, which includes the Management Information Circular and proxy forms [1] - The Annual General Meeting (AGM) is scheduled for December 17, 2025, at 12:30 PM GMT in London, UK [1] - The AGM will take place at the offices of SP Angel Corporate Finance LLP, located at Prince Frederick House, 35-39 Maddox Street, London [1]